Dan Groman - Jan 25, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Technology Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Jan 25, 2023
Transactions value $
-$109,522
Form type
4
Date filed
1/27/2023, 06:19 PM
Previous filing
Jan 19, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +22K +27.14% $0.00 103K Jan 25, 2023 Direct F1
transaction ENFN Class A Common Stock Tax liability -$110K -9.22K -8.95% $11.88 93.7K Jan 25, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan (the "Shares").
F2 Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Shares to the reporting person.